S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

CHRS Coherus BioSciences Inc

2.13

0.07 (3.40%)

May 02 2024 - Closed

Delayed by 15 minutes

Coherus gains after issuing long-term guidance

To read the full story on Seeking Alpha, click here.

Coherus BioSciences (NASDAQ:CHRS)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Coherus BioSciences Charts.

Coherus BioSciences (NASDAQ:CHRS)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Coherus BioSciences Charts.

Coherus BioSciences Inc News

Coherus to Report First Quarter 2024 Financial Results on May 9, 2024
Wednesday 1 May 2024 (1 day ago) • GlobeNewswire Inc.

Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Wednesday 24 April 2024 (1 week ago) • GlobeNewswire Inc.

Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual Meeting
Monday 8 April 2024 (4 weeks ago) • GlobeNewswire Inc.

Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update
Wednesday 13 March 2024 (2 months ago) • GlobeNewswire Inc.

Coherus to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024
Tuesday 5 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 4 March 2024 (2 months ago) • Edgar (US Regulatory)

Coherus Completes Divestiture of Ophthalmology Franchise
Monday 4 March 2024 (2 months ago) • GlobeNewswire Inc.

Coherus BioSciences Announces New Employment Inducement Grants
Friday 23 February 2024 (2 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 22 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Thursday 22 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 22 February 2024 (2 months ago) • Edgar (US Regulatory)

Coherus Announces U.S. Launch of UDENYCA ONBODY™ a Novel and Proprietary State-of-the-Art Delivery System for pegfilgrastim-cbqv
Wednesday 21 February 2024 (2 months ago) • GlobeNewswire Inc.

More Coherus BioSciences Inc News Articles

Voip Pal Com (QB)

BlackStar Enterprise (PK)

Global Developments (PK)

Brookmount Explorations (PK)

Trump Media and Technology

Globestar Therapeutics (PK)

Atacama Resources (PK)

International Star (PK)

CBD of Denver (PK)

Bell Buckle (PK)

Mullen Automotive

Therapeutic Solutions (PK)

Moon Equity (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions